Sanofi embarks on an $845M gene therapy R&D odyssey with Voyager
February 11, 2015 | By John Carroll
Sanofi subsidiary Genzyme is tying up with gene therapy upstart Voyager Therapeutics, gambling $100 million upfront on the hot field and promising up to $745 million in milestones for their partnership on a full slate of development programs.
http://www.fiercebiotech.com/story/sanofi-embarks-845m-gene-therapy-odyssey-voyager/2015-02-11
Here's Dirk's blog from a year ago when his buddy and ex boss Mark Kay's new Co Voyager was announced :
http://rnaitherapeutics.blogspot.com.au/2014/02/voyager-therapeutics-sets-out-to.html
- Forums
- ASX - By Stock
- BLT
- Sanofi Signs Benitec's closest competitor Voyager for $845M
Sanofi Signs Benitec's closest competitor Voyager for $845M
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)